文献速递瓣膜外科

二尖瓣修复术后复发性二尖瓣反流对临床结局影响的综合回顾与荟萃分析

The impact of recurrent mitral regurgitation after surgical or transcatheter mitral valve repair: a comprehensive review and a meta-analysis.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2025-01-01

该荟萃分析纳入22项研究、5804例患者(960例复发MR),比较外科或经导管二尖瓣修复术后复发性二尖瓣反流(MR)对临床结局的影响。结果显示复发性MR总体合并发生率为16.54%,且与再手术、心血管死亡、再入院、心衰及NYHA III/IV级比例升高相关;但原发性MR复发与NYHA III/IV级无显著关联。

要点

  • 复发性MR总体合并发生率为16.54%。
  • 复发性MR与再手术、心血管死亡、再入院和心衰风险升高相关。
  • 原发性MR复发与NYHA III/IV级无显著关联。

核心结论

  • 复发性MR与再手术、再入院、心血管死亡、心衰发生率及NYHA III/IV级比例升高相关。
  • 原发性MR复发与NYHA III/IV级无显著关联。

研究设计与样本

  • 检索Medline、EMBASE、PubMed和Web of Science(2000年1月至2024年8月)的原始研究。
  • 最终纳入22项研究,共5804例患者,其中960例存在复发性MR。
  • 采用合并比值比(OR)及95%置信区间(CI)评估临床结局风险。

主要发现

  • 复发性MR总体合并发生率为16.54%。
  • 继发性或原发性MR患者复发后再手术率升高(OR=6.25,95%CI 2.95-14.41,P<0.001;或OR=22.54,95%CI 14.96-33.98,P<0.001)。
  • 继发性或原发性MR患者复发后心血管死亡率升高(OR=5.26,95%CI 2.35-11.77,P<0.001;或OR=1.68,95%CI 1.32-2.14,P<0.001)。
  • 继发性MR复发者再入院(OR=3.95,95%CI 2.56-6.10,P<0.001)、心衰发生率(OR=2.87,95%CI 1.75-5.11,P<0.001)及NYHA III/IV级比例(OR=5.40,95%CI 3.01-9.70,P<0.001)均升高。
  • 原发性MR复发与NYHA III/IV级无显著关联(OR=1.02,95%CI 0.47-2.22,P=0.96)。

临床怎么用

  • 二尖瓣修复术后应监测复发性MR,因其与再手术、心衰和死亡风险升高相关。
  • 对继发性MR复发患者需关注心衰症状及NYHA分级变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recurrent mitral regurgitation (MR) is typically defined as MR that is moderate or severe on follow-up echocardiography after the intervention. This meta-analysis summarizes the results of all available studies on the impact of recurrent MR on clinical outcomes after the intervention. METHODS: Medline, EMBASE, PubMed and Web of Science were searched from January 2000 to August 2024 for original studies reporting outcomes about the clinical impact of recurrent MR. Five clinical outcomes were analysed: reoperation, cardiovascular deaths, readmission, heart failure and New York Heart Association (NYHA) functional classification. The summary odds ratio (OR) with the 95% confidence interval (CI) was used to assess the risk of clinical outcomes. RESULTS: A total of 22 studies were included in the final analysis, involving 5,804 patients, of which 960 had recurrent MR. The overall pooled incidence of recurrent MR is 16.54%. Secondary or primary patients with MR with recurrent MR after an intervention had higher rates of reoperation [(OR = 6.25, 95% CI, 2.95-14.41; P < 0.001) or (OR = 22.54, 95% CI, 14.96-33.98; P < 0.001)]or of cardiovascular death [(OR = 5.26, 95% CI, 2.35-11.77; P < 0.001) or (OR = 1.68, 95% CI, 1.32-2.14; P < 0.001)]. The rates were also high for readmission (OR = 3.95, 95% CI, 2.56-6.10; P < 0.001), heart failure incidence (OR = 2.87, 95% CI, 1.75-5.11; P < 0.001) and the number of NYHA functional class III/IV (OR = 5.40, 95% CI, 3.01-9.70; P < 0.001) for recurrent MR of secondary MR. However, no significant association was found between recurrent MR of primary MR and the incidence of NYHA functional class III/IV (OR = 1.02, 95% CI, 0.47-2.22; P = 0.96). CONCLUSIONS: Recurrent MR is associated with higher rates of reoperations, readmissions, cardiovascular deaths, incidences of heart failure and NYHA functional class III/IV numbers. However, recurrent MR of primary MR is not correlated with NYHA functional class III/IV.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Yu C, Arjomandi Rad A, He H, et al. The impact of recurrent mitral regurgitation after surgical or transcatheter mitral valve repair: a comprehensive review and a meta-analysis. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40300102. doi:10.1093/icvts/ivaf109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。